TP53 and uterine cervix carcinoma in situ: The authors believe that the markers p53 and p63 are reliable and can distinguish reactive changes from CIN I, while all three biomarkers (Ki-67, p53, and p63) showed a high degree of sensitivity and specificity for the differential diagnosis of CIN III, CIN II, and CIN I [31].